Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

QGEN stock hub

Qiagen N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

QGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.8B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

QGEN

In the news

Latest news · QGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.3

P25 12.3P50 18.4P75 33.1

Trailing P/E17

P25 14.9P50 23.2P75 38.5

ROE11.9

P25 -105.6P50 -46.5P75 -3.1

ROIC10.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All QGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

280

Groups with data

Currency

USD

Showing 280 of 280 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001015820
Company name	Qiagen N.V.
Country	Netherlands
Country code	US
Cusip	N72482123
Employees	5,700
Employees Change	0%
Employees Change Percent	0
Enterprise value	$7.8B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	1996-06-28
Isin	NL0015002SN0
Last refreshed	2026-05-10
Market cap	$6.8B
Market cap category	Mid-Cap
Price	$33.04
Price currency	USD
Rev Per Employee	368,221.58x
Sector	Healthcare
Sic	2836
Symbol	QGEN
Website	https://www.qiagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.89%
EV Earnings	19.48x
EV Sales Forward	3.45x
EV/EBIT	14.47x
EV/EBITDA	10.81x
EV/FCF	19.05x
EV/Sales	3.73x
FCF yield	6.02%
Forward P/E	13.26x
P/B ratio	2.05x
P/E ratio	17.03x
P/S ratio	3.26x
PE Ratio10 Y	74.68x
PE Ratio3 Y	54.69x
PE Ratio5 Y	42.86x
PEG ratio	2.09x
PS Forward	3.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.8%
EBITDA Margin	34.52%
FCF margin	19.59%
Gross margin	66%
Gross Profit	$1.4B
Gross Profit Growth	3.57%
Gross Profit Growth Q	-0.96%
Gross Profit Growth3 Y	1.14%
Gross Profit Growth5 Y	-0.57%
Net Income	$402.2M
Net Income Growth	329.32%
Net Income Growth Q	-25.03%
Net Income Growth Years	1%
Net Income Growth3 Y	4.45%
Net Income Growth5 Y	-2.16%
Pretax Margin	21.75%
Profit Margin	19.16%
Profit Per Employee	$70,555
Profitable Years	6
ROA	5.98
Roa5y	5.61
ROCE	10.21
ROE	11.93
Roe5y	11.16
ROIC	10.79
Roic5y	10.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.31%
Cagr15y	2.97%
Cagr1y	-22.24%
Cagr20y	3.93%
Cagr3y	-10.34%
Cagr5y	-7.01%
Div CAGR3	22.59%
Div CAGR5	13%
EPS Growth	338.2
EPS Growth Q	-24.55
EPS Growth Years	1
EPS Growth3 Y	4.12
EPS Growth5 Y	-1.94
FCF Growth	-18.69%
FCF Growth Q	-43.92%
FCF Growth3 Y	-2.72%
FCF Growth5 Y	-0.01%
OCF Growth	-9.56%
OCF Growth Q	-27.99%
OCF Growth10 Y	7.33%
OCF Growth3 Y	2%
OCF Growth5 Y	1.52%
Revenue Growth	4.79x
Revenue Growth Q	1.83x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	1.65x
Revenue Growth5 Y	0.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$5.8B
Cash	$646.3M
Current Assets	$1.5B
Current Liabilities	$479.1M
Debt	$1.6B
Debt EBITDA	$2.19
Debt Equity	$0.49
Debt FCF	$4
Equity	$3.3B
Interest Coverage	14.63
Liabilities	$2.5B
Long Term Assets	$4.2B
Long Term Liabilities	$2B
Net Cash	$-1B
Net Cash By Market Cap	$-14.64
Net Debt EBITDA	$1.38
Net Debt Equity	$0.3
Net Debt FCF	$2.43
Tangible Book Value	$268.2M
Tangible Book Value Per Share	$1.3
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.21
Inventory Turnover	2.42
Net Working Capital	$414.9M
Quick ratio	2.18
Working Capital	$1.1B
Working Capital Turnover	$1.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.17%
Dividend Growth	92.5%
Dividend Growth Years	3%
Dividend per share	$2.41
Dividend Years	3
Dividend Yield	7.3%
Ex Div Date	2026-01-08
Last Dividend	$2.29
Payout Frequency	Semi-Annual
Payout Ratio	131.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	52.48%
1Y total return	-22.22%
200-day SMA	47.28
3Y total return	-27.94%
50-day SMA	40.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-30.45%
All Time High	67.81
All Time High Change	-51.27%
All Time High Date	2000-07-17
All Time Low	2.03
All Time Low Change	1,529.19%
All Time Low Date	1996-07-16
ATR	1.08
Beta	0.64
Beta1y	0.73
Beta2y	0.63
Ch YTD	-30.2
High	33.44
High52	57.82
High52 Date	2026-01-20
High52ch	-42.85%
Low	32.92
Low52	32.92
Low52 Date	2026-05-08
Low52ch	0.36%
Ma50ch	-17.77%
Premarket Change Percent	0.12
Premarket Price	$33.55
Premarket Volume	9,793
Price vs 200-day SMA	-30.12%
RSI	25.03
RSI Monthly	34.34
RSI Weekly	28.36
Sharpe ratio	-0.8x
Sortino ratio	-0.98
Total Return	7.13%
Tr YTD	-26.65
Tr15y	55.05%
Tr1m	-17.67%
Tr1w	-3.53%
Tr3m	-35.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	1
Analyst Price Target Top	$50
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.54
Earnings EPS Estimate Growth	3.85
Earnings Revenue Estimate	498,648,000x
Earnings Revenue Estimate Growth	3.24x
Operating Income	$541.5M
Operating Income Growth	3.5
Operating Income Growth Q	-9.77
Operating Income Growth3 Y	5.11
Operating Income Growth5 Y	-2.92
Operating margin	25.8
Price target	$45.12
Price Target Change	$36.56
Price Target Change Top	$51.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	205,449,013%
Float Percent	99.35%
Net Borrowing	208,151,000
Shares Insiders	0.56%
Shares Institutions	74.56%
Shares Out	206,800,618
Shares Qo Q	0.57%
Shares Yo Y	0.17%
Short Float	2.83%
Short Ratio	3.68
Short Shares	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$363.5M
Average Volume	2,170,154.1x
Bv Per Share	16.15
CAPEX	$-204M
Ch10y	31.05
Ch15y	33.26
Ch1m	-17.67
Ch1w	-3.53
Ch1y	-26.37
Ch20y	85.69
Ch3m	-35.15
Ch3y	-35.62
Ch5y	-37.87
Ch6m	-27.94
Change	-1.4%
Change From Open	-1.2
Close	33.51
Days Gap	-0.21
Depreciation Amortization	183,049,000
Dollar Volume	54,773,811.1
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$541.5M
EBITDA	$724.6M
EPS	$1.94
F Score	5
FCF	$411.2M
FCF EV Yield	5.25x
FCF Per Share	$1.99
Financing CF	-395,931,000
Fiscal Year End	December
Founded	1,986
Goodwill	2,695,980,000
Graham Number	26.5544
Graham Upside	-19.63
Income Tax	$54.4M
Investing CF	-213,886,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2026-01-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-20
Lynch Fair Value	$9.7
Lynch Upside	-70.64
Ma150	46.33
Ma150ch	-28.69%
Ma20	37.43
Ma20ch	-11.72%
Net CF	7,533,000
Next Earnings Date	2026-08-04
Open	33.44
Optionable	Yes
P FCF Ratio	16.62
P OCF Ratio	11.11
Position In Range	23.08
Post Close	33.04
Postmarket Change Percent	-0.92
Postmarket Price	$32.74
Ppne	914,789,000
Pre Close	33.51
Price Date	2026-05-08
Price EBITDA	$9.43
Ptbv Ratio	25.47
Relative Volume	0.76x
Revenue	2,098,863,000x
SBC By Revenue	2.27x
Share Based Comp	47,712,000
Tax By Revenue	2.59x
Tax Rate	11.91%
Tr20y	116.06%
Tr6m	-24.28%
Volume	1,657,803
Z Score	4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

QGEN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.3%

$2.41 annual per share

Payout ratio

+131.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.0%

3 consecutive years of growth

Total shareholder yield

+7.1%

Next ex-dividend date: 2026-01-08

Performance

QGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns QGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.6%

Float: +99.3% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

QGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

25.0

Below 30: short-term oversold

Price vs 200-day MA

-30.1%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

-0.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About QGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current QGEN stock rating?

Qiagen N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full QGEN analysis?

The full report lives at /stocks/QGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for QGEN?

The latest report frames QGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the QGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.